Side effects of multiple myeloma treatments

Sarah Bailly, Sarah Amat, Catherine Percy, Thomas Gérard, Laurane Lallemand, Aline Munting, Marie-Christiane Vekemans Published in the journal : January 2020 Category : Hematology/Oncology

Summary :

The prolonged use of new drugs such as proteasome inhibitors, immunomodulators, and monoclonal antibodies in the treatment of multiple myeloma is associated with adverse side effects that represent a daily challenge for physicians. We propose a series of recommendations based on clinical cases. Key Words Multiple myeloma, side effect, proteasome inhibitor, immunomodulator, monoclonal antibody, case report